Background: PIM-Taiwan criteria were first established in 2010 for potentially inappropriate
medications (PIMs). Currently, updating of PIM criteria is mandatory because of newly …

Objectives Ischaemic heart diseases (IHDs) are a leading cause of death worldwide.
Although prescribing according to guidelines improves health outcomes, it remains …

Background Pharmaceuticals make an important contribution to people's health. Medicines,
however, are frequently not used appropriately. Improving the use of medicines can improve …

Background Several measures are in force in Switzerland to control the cost of drugs, but
are not effective enough. There are many determinants influencing these expenditures …

More than 40 years after the Alma-Ata Declaration on Primary Health Care, it is time to take
stock. A look back at the evolution of pharmaceutical policies reveals the extent to which …

This paper is a comprehensive case study on how the Korean civil registration and vital
statistics (CRVS) system facilitates achievement of universal health coverage (UHC) in the …

Increasing expenditures on retail pharmaceuticals bring a critical challenge to the financial
stability of healthcare systems worldwide. Policy makers have reacted by introducing a …

Generic prescribing is prescribing medicines by the prescriber using the international non-
proprietary name, leaving the choice to the pharmacist to either dispense the brand or its …

Purpose Choosing the optimal lot size in drug manufacturing has critical implications for
process scheduling and economic performance. There are no rigorous models addressing …

Objectives To investigate the quality of drug treatment in older people from a broad family
physician perspective, and to provide evidence for power calculations in full-scale studies …